The fragile X syndrome is due to the absence of the FMR1 protein, FMRP. A mouse Finn knockout exhibits cognitive deficiencies and macroorchidism, recapitulating features of the human syndrome. Despite advances in our understanding of FMRP function and the consequence of its absence, many simple, yet fundamental questions remain elusive. A critical need throughout the entire gamut of such research is the availability of mice and cultured cells where Fmrp levels are easily modulated. The PL proposes here the development of several such models. Several lines of mice engineered where the Fmrp levels can be regulated by doxycycline exposure will be developed These will range from the traditional transgenic animal with the tetracycline-response element (TRE) promoter driving the Fmr1 cDNA on a knockout background to more sophisticated approaches. One novel approach maintains normal alternative splicing variation and normal cell expression specificity by replacing, in embryonic stem cells, the normal mouse FMR1 promoter with a TRE without otherwise modifying the murine gene. Another novel approach will be the fusion of a HIV-TAT transducing domain with the CRE recombinase. Purified fusion protein can easily enter all cell types and delete the genomic interval between direct lox repeats. Using this approach the PL will develop the ability to selectively ablate FMR1 in discreet organs and brain regions. From all mouse models developed, immortalized cell lines will also be developed for experiments where cultured cells would be most appropriate. All models will be rigorously tested for parameters of inducible FMR1 expression and decay. Using these models the PL will test fundamental issues involving fragile X syndrome, ranging from biochemical and cell biological questions to determining if FMRP expression is essential during development or if later expression of FMRP can influence the cognitive deficit. Such data is of fundamental importance in the consideration of therapeutic interventions. Developing, testing, and utilizing these mice and cells derived from them should substantially advance the analysis and understanding of FMRP function and the consequences of its absence.

Project Start
1997-09-10
Project End
2006-06-30
Budget Start
1997-10-01
Budget End
1998-09-30
Support Year
4
Fiscal Year
2001
Total Cost
$172,473
Indirect Cost
Name
Emory University
Department
Type
DUNS #
042250712
City
Atlanta
State
GA
Country
United States
Zip Code
30322
Spath, Marian A; Feuth, Ton B; Smits, Arie P T et al. (2011) Predictors and risk model development for menopausal age in fragile X premutation carriers. Genet Med 13:643-50
Spath, M A; Feuth, T B; Allen, E G et al. (2011) Intra-individual stability over time of standardized anti-Mullerian hormone in FMR1 premutation carriers. Hum Reprod 26:2185-91
Wang, Houping; Dictenberg, Jason B; Ku, Li et al. (2008) Dynamic association of the fragile X mental retardation protein as a messenger ribonucleoprotein between microtubules and polyribosomes. Mol Biol Cell 19:105-14
Allen, E G; Sullivan, A K; Marcus, M et al. (2007) Examination of reproductive aging milestones among women who carry the FMR1 premutation. Hum Reprod 22:2142-52
Anido, Aimee; Carlson, Lisa M; Sherman, Stephanie L (2007) Attitudes toward fragile X mutation carrier testing from women identified in a general population survey. J Genet Couns 16:97-104
Smith, Karen T; Nicholls, Robert D; Reines, Daniel (2006) The gene encoding the fragile X RNA-binding protein is controlled by nuclear respiratory factor 2 and the CREB family of transcription factors. Nucleic Acids Res 34:1205-15
Garber, Kathryn; Smith, Karen T; Reines, Danny et al. (2006) Transcription, translation and fragile X syndrome. Curr Opin Genet Dev 16:270-5
Li, Wen; Xia, Jin-tang; Feng, Yue (2006) Microtubule stability and MAP1B upregulation control neuritogenesis in CAD cells. Acta Pharmacol Sin 27:1119-26
Anido, Aimee; Carlson, Lisa M; Taft, Lisa et al. (2005) Women's attitudes toward testing for fragile X carrier status: a qualitative analysis. J Genet Couns 14:295-306
Nakamoto, Mika; Jin, Peng; O'Donnell, William T et al. (2005) Physiological identification of human transcripts translationally regulated by a specific microRNA. Hum Mol Genet 14:3813-21

Showing the most recent 10 out of 45 publications